New AI vaccine developed 15 Sep 2008

Kent Van Kampen, Vaxin's COO and an authority on vaccine development: "Our vaccine uses a neutered cold virus to carry a tiny snippet of influenza DNA, rather than the entire influenza virus," Van Kampen said. "When the immune system responds, it actually learns how to be immune to the target disease - avian influenza in this case."

This vaccine has been shown to provide excellent protection when administered to poultry before hatching. Vaxin has utilised these advances to develop a version of the vaccine that will soon be tested in humans.